Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)
- PMID: 18344424
- PMCID: PMC2384129
- DOI: 10.1182/blood-2007-09-110940
Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)
Abstract
The decreased survival of von Willebrand factor (VWF) in plasma has been implicated as a mechanism in a subset of type 1 von Willebrand disease (VWD) patients. We have previously reported that the ratio of plasma levels of VWF and its propeptide (VWFpp) can be used to identify patients with reduced VWF survival. In this study, we report the assay of VWFpp and VWF:Ag in 19 individuals recruited from 6 European centers within the MCMDM-1VWD study. Eight individuals had a VWF:Ag level less than 30 IU/dL. Seven of these patients had a robust desmopressin response and significantly reduced VWF half-life that was predicted by a markedly increased steady-state plasma VWFpp/VWF:Ag ratio. VWF mutations previously associated with reduced VWF survival were identified in each of the 7 individuals. Thus, a substantially increased ratio of steady-state VWFpp/VWF:Ag predicted a reduced VWF half-life in patients with markedly decreased VWF:Ag levels. These data indicate that a reduced VWF survival is found in a subpopulation of patients with type 1 VWD. The systematic assay of both plasma VWF and the VWF propeptide in moderately severe type 1 VWD patients may identify patients with a reduced VWF survival phenotype.
Figures





Similar articles
-
Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival.Blood. 2006 Nov 15;108(10):3344-51. doi: 10.1182/blood-2006-04-015065. Epub 2006 Jul 11. Blood. 2006. PMID: 16835381 Free PMC article.
-
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8. Acta Haematol. 2009. PMID: 19506359 Review.
-
Assessment of von Willebrand factor propeptide improves the diagnosis of von Willebrand disease.Semin Thromb Hemost. 2011 Jul;37(5):456-63. doi: 10.1055/s-0031-1281029. Epub 2011 Nov 18. Semin Thromb Hemost. 2011. PMID: 22102187 Review.
-
Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease.Br J Haematol. 2008 Oct;143(1):107-14. doi: 10.1111/j.1365-2141.2008.07311.x. Epub 2008 Aug 7. Br J Haematol. 2008. PMID: 18691167
-
VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.Blood. 2013 Mar 21;121(12):2336-9. doi: 10.1182/blood-2012-09-455089. Epub 2013 Jan 24. Blood. 2013. PMID: 23349392 Free PMC article.
Cited by
-
Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease.J Thromb Haemost. 2012 Jul;10(7):1425-32. doi: 10.1111/j.1538-7836.2012.04747.x. J Thromb Haemost. 2012. PMID: 22507643 Free PMC article.
-
Acquired von Willebrand syndrome: von Willebrand factor propeptide to von Willebrand factor antigen ratio predicts remission status.Blood. 2014 Jul 31;124(5):e1-3. doi: 10.1182/blood-2014-02-557132. Epub 2014 Jun 20. Blood. 2014. PMID: 24951428 Free PMC article.
-
von Willebrand disease.Nat Rev Dis Primers. 2024 Jul 25;10(1):51. doi: 10.1038/s41572-024-00536-8. Nat Rev Dis Primers. 2024. PMID: 39054329 Review.
-
Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies.Blood. 2024 Apr 4;143(14):1414-1424. doi: 10.1182/blood.2023022457. Blood. 2024. PMID: 38142407 Free PMC article.
-
Standardization of von Willebrand factor propeptide: value assignment to the WHO 6th IS Factor VIII/von Willebrand factor, plasma (07/316).J Thromb Haemost. 2012 May;10(5):959-60. doi: 10.1111/j.1538-7836.2012.04672.x. J Thromb Haemost. 2012. PMID: 22696769 Free PMC article. No abstract available.
References
-
- Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:395–424. - PubMed
-
- Wagner DD. Cell biology of von Willebrand factor. Annu Rev Cell Biol. 1990;6:217–246. - PubMed
-
- Vischer UM, Wagner DD. von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies. Blood. 1994;83:3536–3544. - PubMed
-
- Haberichter SL, Fahs SA, Montgomery RR. Von Willebrand factor storage and multimerization: 2 independent intracellular processes. Blood. 2000;96:1808–1815. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous